CFTR Modulators: Does One Dose Fit All? by Renske van der Meer, Erik B. Wilms, Harry G.M. Heijerman

Get full text

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate by Annemieke Sobels, Koen J. Lentjes, Frank M. J. A. Froeling, Cees van Nieuwkoop, Erik B. Wilms

Get full text

Vancomycin pharmacokinetic model development in patients on intermittent online hemodiafiltration. by Niels Westra, Johannes H Proost, Casper F M Franssen, Erik B Wilms, Marjolijn van Buren, Daan J Touw

Get full text

Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review by Sander G. Kuiper, Maarten Ploeger, Erik B. Wilms, Marleen M. van Dijk, Emiel Leegwater, Robert A. G. Huis in’t Veld, Cees van Nieuwkoop

Get full text

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study by Emiel Leegwater, Lisa Dol, Menno R. Benard, Eveline E. Roelofsen, Nathalie M. Delfos, Machteld van der Feltz, Femke P. N. Mollema, Liesbeth B. E. Bosma, Loes E. Visser, Thomas H. Ottens, Nathalie D. van Burgel, Sesmu M. Arbous, Lahssan H. El Bouazzaoui, Rachel Knevel, Rolf H. H. Groenwold, Mark G. J. de Boer, Leo G. Visser, Frits R. Rosendaal, Erik B. Wilms, Cees van Nieuwkoop

Get full text